RAPP
Rapport TherapeuticsBNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-03
+
Peers tracked
11
U.S. public peers
Grade Position
In line
vs peer average
RAPP vs peer average
61/100
RAPP vs. peer average (B vs. C)
Grade spread
B 6 · C 2 · D 1 · F 1
Graded peers loaded
Coverage
11 graded
100% of tracked
Peer overview
BHVN is the first available peer comparator.
Biohaven is the closest listed neuroscience-development comparator in the candidate set, though it is broader and better covered than Rapport; useful for how CNS pipeline optionality can move valuation ahead of registrational data.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
RAPP
Rapport Therapeutics
BHVN
Biohaven
Grade
B
F
Momentum
83
29
Value
42
41
Sentiment
48
-
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Constructive
Defensive
Grade position vs BHVN
RAPP / BHVN
Grade Position
In line
RAPP vs. peer average (B vs. C)
61/100
Momentum
83
RAPPValue
42
RAPPSentiment
48
-Rotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs RAPP
BHVN is the first peer returned for this comparison set.